SRGA logo

Surgalign Holdings (SRGA) Cash From Financing

SRGA Annual CFF

$24.66 M
-$57.90 M-70.13%

31 December 2022

SRGA Cash From Financing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SRGA Quarterly CFF

-$19.00 K
-$10.91 M-100.17%

31 March 2023

SRGA Quarterly CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SRGA TTM CFF

$11.00 M
-$13.66 M-55.41%

31 March 2023

SRGA TTM CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SRGA Cash From Financing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-70.1%-100.1%-81.6%
3 y3 years-79.5%+89.0%+93.0%
5 y5 years+169.0%-100.1%-90.9%

SRGA Cash From Financing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time-79.5%-100.0%-91.0%

Surgalign Holdings Cash From Financing History

DateAnnualQuarterlyTTM
Mar 2023
-
-$19.00 K(-100.2%)
$11.00 M(-55.4%)
Dec 2022
$24.66 M(-70.1%)
$10.89 M(<-9900.0%)
$24.66 M(+74.4%)
Sept 2022
-
-$7000.00(-105.2%)
$14.14 M(+0.1%)
June 2022
-
$135.00 K(-99.0%)
$14.12 M(-76.4%)
Mar 2022
-
$13.64 M(+3597.3%)
$59.81 M(-27.6%)
Dec 2021
$82.56 M(-131.4%)
$369.00 K(-1576.0%)
$82.56 M(+0.6%)
Sept 2021
-
-$25.00 K(-100.1%)
$82.06 M(-141.1%)
June 2021
-
$45.82 M(+25.9%)
-$199.76 M(-11.8%)
Mar 2021
-
$36.40 M(<-9900.0%)
-$226.47 M(-13.9%)
Dec 2020
-$263.04 M(-318.7%)
-$133.00 K(-100.0%)
-$263.04 M(+1.3%)
Sept 2020
-
-$281.84 M(-1575.0%)
-$259.57 M(-1149.3%)
June 2020
-
$19.11 M(<-9900.0%)
$24.74 M(+334.3%)
Mar 2020
-
-$173.00 K(-105.2%)
$5.70 M(-95.3%)
Dec 2019
$120.30 M(+2839.1%)
$3.33 M(+35.1%)
$120.30 M(+3.3%)
Sept 2019
-
$2.47 M(+3583.6%)
$116.50 M(+5.4%)
June 2019
-
$67.00 K(-99.9%)
$110.51 M(+8.1%)
Mar 2019
-
$114.43 M(<-9900.0%)
$102.25 M(+2398.2%)
Dec 2018
$4.09 M(-111.5%)
-$460.00 K(-87.0%)
$4.09 M(+423.4%)
Sept 2018
-
-$3.52 M(-57.0%)
$782.00 K(-103.0%)
June 2018
-
-$8.19 M(-150.3%)
-$25.71 M(+49.7%)
Mar 2018
-
$16.27 M(-531.4%)
-$17.18 M(-51.9%)
Dec 2017
-$35.73 M(-1075.2%)
-$3.77 M(-87.4%)
-$35.73 M(+10.7%)
Sept 2017
-
-$30.02 M(-8877.2%)
-$32.27 M(-914.0%)
June 2017
-
$342.00 K(-115.0%)
$3.96 M(+38.1%)
Mar 2017
-
-$2.28 M(+644.0%)
$2.87 M(-21.7%)
Dec 2016
$3.66 M(-41.6%)
-$307.00 K(-104.9%)
$3.66 M(-24.3%)
Sept 2016
-
$6.21 M(-926.2%)
$4.84 M(-3.5%)
June 2016
-
-$752.00 K(-49.5%)
$5.01 M(-4.2%)
Mar 2016
-
-$1.49 M(-271.5%)
$5.23 M(-16.6%)
Dec 2015
$6.27 M(-20.3%)
$869.00 K(-86.4%)
$6.27 M(-11.8%)
Sept 2015
-
$6.39 M(-1298.3%)
$7.11 M(+3546.2%)
June 2015
-
-$533.00 K(+18.7%)
$195.00 K(-90.4%)
Mar 2015
-
-$449.00 K(-126.3%)
$2.04 M(-74.1%)
Dec 2014
$7.87 M(-93.2%)
$1.71 M(-422.9%)
$7.87 M(+37.1%)
Sept 2014
-
-$528.00 K(-140.3%)
$5.74 M(-95.3%)
June 2014
-
$1.31 M(-75.7%)
$122.72 M(+1.4%)
Mar 2014
-
$5.38 M(-1363.6%)
$121.03 M(+4.7%)
Dec 2013
$115.62 M(>+9900.0%)
-$426.00 K(-100.4%)
$115.62 M(-0.8%)
Sept 2013
-
$116.45 M(<-9900.0%)
$116.58 M(>+9900.0%)
June 2013
-
-$379.00 K(+1795.0%)
$218.00 K(-64.6%)
Mar 2013
-
-$20.00 K(-103.7%)
$616.00 K(+19.1%)
Dec 2012
$517.00 K(-143.2%)
$536.00 K(+561.7%)
$517.00 K(-48.9%)
Sept 2012
-
$81.00 K(+326.3%)
$1.01 M(+31.4%)
June 2012
-
$19.00 K(-116.0%)
$770.00 K(-162.9%)
Mar 2012
-
-$119.00 K(-111.5%)
-$1.22 M(+2.3%)
DateAnnualQuarterlyTTM
Dec 2011
-$1.20 M(-89.6%)
$1.03 M(-740.4%)
-$1.20 M(-90.5%)
Sept 2011
-
-$161.00 K(-91.8%)
-$12.65 M(+14.2%)
June 2011
-
-$1.98 M(+2070.3%)
-$11.08 M(+1.9%)
Mar 2011
-
-$91.00 K(-99.1%)
-$10.88 M(-5.5%)
Dec 2010
-$11.51 M(-280.8%)
-$10.42 M(-840.2%)
-$11.51 M(-480.1%)
Sept 2010
-
$1.41 M(-179.4%)
$3.03 M(-14.1%)
June 2010
-
-$1.77 M(+146.3%)
$3.52 M(-37.8%)
Mar 2010
-
-$720.00 K(-117.5%)
$5.66 M(-11.0%)
Dec 2009
$6.36 M(+114.7%)
$4.11 M(+116.0%)
$6.36 M(+72.7%)
Sept 2009
-
$1.90 M(+421.6%)
$3.69 M(-7.8%)
June 2009
-
$365.00 K(-2247.1%)
$4.00 M(+22.1%)
Mar 2009
-
-$17.00 K(-101.2%)
$3.27 M(+10.4%)
Dec 2008
$2.96 M(-307.9%)
$1.43 M(-35.3%)
$2.96 M(+161.4%)
Sept 2008
-
$2.21 M(-717.0%)
$1.13 M(-207.4%)
June 2008
-
-$359.00 K(+10.5%)
-$1.06 M(-4.5%)
Mar 2008
-
-$325.00 K(-18.1%)
-$1.11 M(-22.4%)
Dec 2007
-$1.43 M(-34.6%)
-$397.00 K(-1688.0%)
-$1.43 M(-7.9%)
Sept 2007
-
$25.00 K(-106.1%)
-$1.55 M(-26.1%)
June 2007
-
-$409.00 K(-36.6%)
-$2.10 M(-7.1%)
Mar 2007
-
-$645.00 K(+24.0%)
-$2.26 M(+3.6%)
Dec 2006
-$2.18 M(-110.2%)
-$520.00 K(-0.6%)
-$2.18 M(+4.5%)
Sept 2006
-
-$523.00 K(-8.1%)
-$2.09 M(-111.6%)
June 2006
-
-$569.00 K(+0.4%)
$17.93 M(-14.4%)
Mar 2006
-
-$567.00 K(+32.8%)
$20.94 M(-1.9%)
Dec 2005
$21.36 M(+199.8%)
-$427.00 K(-102.2%)
$21.36 M(-40.5%)
Sept 2005
-
$19.50 M(+699.0%)
$35.86 M(+3051.2%)
June 2005
-
$2.44 M(-1684.4%)
$1.14 M(-140.4%)
Mar 2005
-
-$154.00 K(-101.1%)
-$2.82 M(-139.5%)
Dec 2004
$7.12 M(+809.7%)
$14.08 M(-192.5%)
$7.12 M(-208.3%)
Sept 2004
-
-$15.23 M(+905.7%)
-$6.58 M(-164.7%)
June 2004
-
-$1.51 M(-115.5%)
$10.17 M(-9.6%)
Mar 2004
-
$9.79 M(+2475.0%)
$11.24 M(+1336.1%)
Dec 2003
$783.00 K(-85.8%)
$380.00 K(-75.0%)
$783.00 K(-88.7%)
Sept 2003
-
$1.52 M(-447.1%)
$6.92 M(+38.3%)
June 2003
-
-$437.00 K(-35.5%)
$5.00 M(-1.4%)
Mar 2003
-
-$677.00 K(-110.4%)
$5.07 M(-7.8%)
Dec 2002
$5.50 M(-51.7%)
$6.51 M(-1728.5%)
$5.50 M(+43.2%)
Sept 2002
-
-$400.00 K(+8.7%)
$3.84 M(-60.7%)
June 2002
-
-$368.00 K(+49.0%)
$9.77 M(+5.6%)
Mar 2002
-
-$247.00 K(-105.1%)
$9.26 M(-18.7%)
Dec 2001
$11.39 M(-75.8%)
$4.85 M(-12.3%)
$11.39 M(+74.3%)
Sept 2001
-
$5.54 M(-726.8%)
$6.53 M(+554.6%)
June 2001
-
-$883.00 K(-146.9%)
$998.00 K(-46.9%)
Mar 2001
-
$1.88 M
$1.88 M
Dec 2000
$46.97 M(+262.6%)
-
-
Dec 1999
$12.95 M
-
-

FAQ

  • What is Surgalign Holdings annual cash flow from financing activities?
  • What is the all time high annual CFF for Surgalign Holdings?
  • What is Surgalign Holdings annual CFF year-on-year change?
  • What is Surgalign Holdings quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Surgalign Holdings?
  • What is Surgalign Holdings quarterly CFF year-on-year change?
  • What is Surgalign Holdings TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Surgalign Holdings?
  • What is Surgalign Holdings TTM CFF year-on-year change?

What is Surgalign Holdings annual cash flow from financing activities?

The current annual CFF of SRGA is $24.66 M

What is the all time high annual CFF for Surgalign Holdings?

Surgalign Holdings all-time high annual cash flow from financing activities is $120.30 M

What is Surgalign Holdings annual CFF year-on-year change?

Over the past year, SRGA annual cash flow from financing activities has changed by -$57.90 M (-70.13%)

What is Surgalign Holdings quarterly cash flow from financing activities?

The current quarterly CFF of SRGA is -$19.00 K

What is the all time high quarterly CFF for Surgalign Holdings?

Surgalign Holdings all-time high quarterly cash flow from financing activities is $116.45 M

What is Surgalign Holdings quarterly CFF year-on-year change?

Over the past year, SRGA quarterly cash flow from financing activities has changed by -$13.66 M (-100.14%)

What is Surgalign Holdings TTM cash flow from financing activities?

The current TTM CFF of SRGA is $11.00 M

What is the all time high TTM CFF for Surgalign Holdings?

Surgalign Holdings all-time high TTM cash flow from financing activities is $122.72 M

What is Surgalign Holdings TTM CFF year-on-year change?

Over the past year, SRGA TTM cash flow from financing activities has changed by -$48.81 M (-81.61%)